Medicenna Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is April - March.

Millions CAD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Mar '26 Mar 9, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2020 - 2016
Market Capitalization	68	77	130	61	92	270	Upgrade
Market Cap Growth	-28.90%	-40.82%	111.36%	-33.17%	-66.08%	60.46%	Upgrade
Enterprise Value	58	47	108	25	68	237	Upgrade
Last Close Price	0.82	0.98	1.86	0.88	1.65	5.11	Upgrade
PB Ratio	11.01	4.01	24.95	2.08	4.40	7.09	Upgrade
P/TBV Ratio	11.10	4.03	25.23	2.08	4.42	7.10	Upgrade
Debt / Equity Ratio	0.02	0.01	-	-	-	0.00	Upgrade
Net Debt / Equity Ratio	-1.69	-1.29	-3.27	-1.14	-0.99	-1.06	Upgrade
Net Debt / EBITDA Ratio	0.47	1.21	0.91	2.06	0.92	2.33	Upgrade
Net Debt / FCF Ratio	0.57	1.49	1.04	2.65	0.87	2.64	Upgrade
Quick Ratio	2.50	6.21	6.34	4.95	8.33	9.93	Upgrade
Current Ratio	2.68	6.35	6.66	5.23	8.92	10.26	Upgrade
Return on Equity (ROE)	-109.78%	-97.22%	-146.88%	-39.94%	-76.56%	-46.54%	Upgrade
Return on Assets (ROA)	-61.57%	-53.68%	-42.00%	-34.02%	-42.75%	-27.10%	Upgrade
Return on Capital Employed (ROCE)	-270.70%	-85.20%	-114.80%	-55.30%	-107.90%	-45.60%	Upgrade
Earnings Yield	-18.99%	-15.40%	-19.66%	-16.40%	-24.62%	-6.40%	Upgrade
FCF Yield	-	-21.56%	-12.55%	-20.65%	-25.72%	-5.66%	Upgrade
Buyback Yield / Dilution	-9.86%	-10.10%	-7.57%	-19.25%	-9.31%	-55.68%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.